SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q4 2023
![SLRX stock - SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q4 2023](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600-768x432.png)
Source: iQoncept / Shutterstock
Salarius Pharmaceuticals (NASDAQ:SLRX) just reported results for the fourth quarter of 2023.
- Salarius Pharmaceuticals reported earnings per share of -22 cents. This was above the analyst estimate for EPS of -$1.01.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/slrx-stock-earnings-salarius-pharmaceuticals-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC